ALOX5AP gene variants show differential association with coronary artery disease in different populations

被引：3

作者：

Alwan A. ^{[1
]}

Youhanna S.C. ^{[1
]}

Platt D.E. ^{[2
]}

El-Sibai M. ^{[1
]}

Yerezian J.S. ^{[1
]}

Deeb M.E. ^{[1
]}

Khazen G. ^{[3
,4
]}

Saadé S. ^{[1
]}

Zreik T.G. ^{[1
]}

El Bayeh H. ^{[1
]}

Maalouf A. ^{[5
]}

Abchee A. ^{[4
]}

Zalloua P.A. ^{[1
,6
,7
]}

机构：

[1] Lebanese American University, Chouran

[2] Computational Genomics, IBM T. J. Watson Research Center, Yorktown, NY 10598, Yorktown Hgts

[3] Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne

[4] American University of Beirut Medical Center, Beirut

[5] School of Medicine, Balamand University, Beirut

[6] Harvard School of Public Health, Boston

[7] School of Medicine, Lebanese American University, Chouran

来源：

Journal of Community Genetics | 2010年 / 1卷 / 3期

关键词：

ALOX5AP; CAD; Inflammation; SNP; Stenosis;

D O I：

10.1007/s12687-010-0015-z

中图分类号：

学科分类号：

摘要：

Coronary artery disease (CAD) is a complex disease with various components, genetic as well as environmental. Previous reports correlating ALOX5AP gene variants and CAD showed conflicting results depending on the population studied. In this study, we examined the contribution of ALOX5AP genetic predisposition to CAD in a group of CAD patients and controls carefully selected from the Lebanese population. We genotyped SNPs for ALOX5AP variants in 289 catheterized patients aged ≤52 years with >50% stenosis in at least one main coronary artery and 227 catheterized control subjects aged 60 years and above with 0% stenosis. Chi-square (X2) tests and logistic regression showed no significant difference in the allele and genotype frequencies between the CAD or myocardial infarction (MI) cases and the healthy controls. Haplotype analysis using PHASE showed that the distribution of the risk haplotypes among cases and controls were not significantly different and had no attributable risk to CAD (P=1.00 and P=0.5, respectively) or MI (P=0.2 and P=0.5, respectively). Our data revealed that ALOX5AP gene variants are not predictors of CAD risk or MI risk among Lebanese patients. © Springer-Verlag 2010.

引用

页码：107 / 115

页数：8

共 21 条

[1]

Abchee A., Puzantian H., Azar S.T., Shbaklo H., Nasrallah A., Sawaya F.J., Et al., Predictors of coronary artery disease in the Lebanese population, Thromb Res, 117, pp. 631-637, (2006)

[2]

Assmann G., Carmena R., Cullen P., Fruchart J.-C., Jossa F., Lewis B., Mancini M., Paoletti R., Coronary heart disease: Reducing the risk: A worldwide view, Circulation, 100, 18, pp. 1930-1938, (1999)

[3]

Girelli D., Martinelli N., Trabetti E., Olivieri O., Cavallari U., Malerba G., Busti F., Friso S., Pizzolo F., Pignatti P.F., Corrocher R., ALOX5AP gene variants and risk of coronary artery disease: An angiography-based study, European Journal of Human Genetics, 15, 9, pp. 959-966, (2007)

[4]

Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., Samani N.J., Gudmundsson G., Grant S.F.A., Thorgeirsson G., Sveinbjornsdottir S., Valdimarsson E.M., Matthiasson S.E., Johannsson H., Gudmundsdottir O., Gurney M.E., Sainz J., Thorhallsdottir M., Andresdottir M., Frigge M.L., Topol E.J., Kong A., Gudnason V., Hakonarson H., Gulcher J.R., Stefansson K., The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and

[5]

Helgadottir A., Manolescu A., Helgason A., Thorleifsson G., Thorsteinsdottir U., Gudbjartsson D.F., Gretarsdottir S., Magnusson K.P., Gudmundsson G., Hicks A., Jonsson T., Grant S.F.A., Sainz J., O'Brien S.J., Sveinbjornsdottir S., Valdimarsson E.M., Matthiasson S.E., Levey A.I., Abramson J.L., Reilly M.P., Vaccarino V., Wolfe M.L., Gudnason V., Quyyumi A.A., Topol E.J., Rader D.J., Thorgeirsson G., Gulcher J.R., Hakonarson H., Kong A., Stefansson K., A variant of the gene encoding leukotriene

[6]

Kajimoto K., Shioji K., Ishida C., Iwanaga Y., Kokubo Y., Tomoike H., Miyazaki S.-I., Nonogi H., Goto Y., Iwai N., Validation of the association between the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a Japanese population, Circulation Journal, 69, 9, pp. 1029-1034, (2005)

[7]

Laxton R., Pearce E., Kyriakou T., Ye S., Association of the lymphotoxin-α gene Thr26Asn polymorphism with severity of coronary atherosclerosis, Genes and Immunity, 6, 6, pp. 539-541, (2005)

[8]

Linsel-Nitschke P., Gotz A., Medack A., Konig I.R., Bruse P., Lieb W., Et al., Genetic variation in the arachidonate 5-lipoxygenaseactivating protein (ALOX5AP) is associated with myocardial infarction in the German population, Clin Sci (Lond), 115, pp. 309-315, (2008)

[9]

Lohmussaar E., Gschwendtner A., Mueller J.C., Org T., Wichmann E., Hamann G., Et al., ALOX5AP gene and the PDE4D gene in a central European population of stroke patients, Stroke, 36, pp. 731-736, (2005)

[10]

Lotzer K., Funk C.D., Habenicht A.J.R., The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1736, 1, pp. 30-37, (2005)

← 1 2 3 →